| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/27/2011 | WO2011133638A2 Epicutaneous patch test chamber |
| 10/27/2011 | WO2011133632A1 Separating target analytes using alternating magnetic fields |
| 10/27/2011 | WO2011133630A1 Isolating a target analyte from a body fluid |
| 10/27/2011 | WO2011133540A2 Capillary biosensor system and its method of use |
| 10/27/2011 | WO2011133529A1 Predictors of pharmacokinetic and pharmacodynamic disposition of carrier-mediated agents |
| 10/27/2011 | WO2011133500A2 Detection and analysis of epigenetic and genetic changes in tumor tissue |
| 10/27/2011 | WO2011133493A2 Allosteric regulation of kinase activity |
| 10/27/2011 | WO2011133477A2 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
| 10/27/2011 | WO2011133453A2 Tray for tissue biopsy samples, methods of making, and methos of using thereof |
| 10/27/2011 | WO2011133450A2 Serology assays |
| 10/27/2011 | WO2011133432A2 Methods to detect and isolate cancer stem cells |
| 10/27/2011 | WO2011133429A1 Cancer-related glycopeptide epitopes, antibodies and methods of use |
| 10/27/2011 | WO2011133424A2 Genetic amplification of iqgap1 in cancer |
| 10/27/2011 | WO2011133418A1 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof |
| 10/27/2011 | WO2011133384A1 Radioactive/nuclear threat monitoring using long detectors |
| 10/27/2011 | WO2011133383A2 Methods and apparatus for determination of halohydrocarbons |
| 10/27/2011 | WO2011133327A1 Method for diagnosing melanocytic proliferations |
| 10/27/2011 | WO2011133284A1 Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof |
| 10/27/2011 | WO2011133215A1 Method of identifying and treating a person having a predisposition to or afflicted with parkinson disease |
| 10/27/2011 | WO2011133175A1 Methods and devices for assessing infertility and/or egg quality |
| 10/27/2011 | WO2011133169A1 Dna intercalator detection |
| 10/27/2011 | WO2011133143A1 Multi-pillar structure for molecular analysis |
| 10/27/2011 | WO2011133105A1 Novel allergen |
| 10/27/2011 | WO2011133082A1 Method for screening the sensitizing properties of chemical compounds |
| 10/27/2011 | WO2011133014A1 Planar micropump with integrated microvalves |
| 10/27/2011 | WO2011132978A2 Fluorescence polarization analysis apparatus including dual light source |
| 10/27/2011 | WO2011132941A2 Tf-bpb specifically binding to transcription factor |
| 10/27/2011 | WO2011132863A2 Water-quality measurement system using a smartphone |
| 10/27/2011 | WO2011132801A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof |
| 10/27/2011 | WO2011132584A1 Membrane potential change detection device and membrane potential change detection method |
| 10/27/2011 | WO2011132182A1 MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES |
| 10/27/2011 | WO2011132175A2 Novel biomarkers and targets for ovarian carcinoma |
| 10/27/2011 | WO2011132079A1 Biofuel degradation sensor based on fluorescence measurements |
| 10/27/2011 | WO2011132077A2 Diagnostic assay |
| 10/27/2011 | WO2011132024A1 Embedded material testing device and method |
| 10/27/2011 | WO2011131980A1 Assay for identification of lrrk2 inhibitors |
| 10/27/2011 | WO2011131934A1 Ubiquitination assay |
| 10/27/2011 | WO2011131914A1 Device for preparing and/or treating a biological sample |
| 10/27/2011 | WO2011131896A2 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 10/27/2011 | WO2011131866A1 Probe for collecting samples, sampling device comprising said probe, and method for collecting samples |
| 10/27/2011 | WO2011131772A1 Means and methods for identifying an increased risk of systemic lupus erythematosus (sle) patients for developing renal manifestations |
| 10/27/2011 | WO2011131747A1 Chimeric polypeptides useful in proximal and dynamic high-throughput screening methods |
| 10/27/2011 | WO2011131652A1 Cxcl5 as a marker of hormone escape in prostate cancer |
| 10/27/2011 | WO2011131594A1 Immobilizing enzymes using plasmas |
| 10/27/2011 | WO2011131471A1 Device for plasma separation by means of a central channel structure |
| 10/27/2011 | WO2011130801A1 Wheat immunoreactivity |
| 10/27/2011 | WO2011130789A1 Tethered enzyme mediated nucleic acid detection |
| 10/27/2011 | WO2011109584A3 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 10/27/2011 | WO2011103424A3 High-resolution analysis devices and related methods |
| 10/27/2011 | WO2011088149A3 Methods for predicting response of triple-negative breast cancer to therapy |
| 10/27/2011 | WO2011081971A3 Fused thiophenes as dual inhibitors of egfr/vegfr and their use in the treatment of cancer |
| 10/27/2011 | WO2011081421A9 Complement c9 as markers for the diagnosis of cancer |
| 10/27/2011 | WO2011081310A3 Peptide marker for cancer diagnosis, and cancer diagnosis method using same |
| 10/27/2011 | WO2011074802A3 Kit for diagnosing prostate cancer and diagnosis method |
| 10/27/2011 | WO2011072205A3 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin) |
| 10/27/2011 | WO2011071256A3 Centrifugal micro-fluidic structure for measuring glycated hemoglobin, centrifugal micro-fluidic device for measuring glycated hemoglobin, and method for measuring glycated hemoglobin |
| 10/27/2011 | WO2011070408A3 Electro-chemical sensor |
| 10/27/2011 | WO2011066503A3 Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 ) |
| 10/27/2011 | WO2011065729A3 Biosensor |
| 10/27/2011 | WO2011063389A3 Normalization of platelet biomarkers |
| 10/27/2011 | WO2011059686A3 Detection of b-cell activating factor as a biomaker for antibody mediated rejection in transplant recipients |
| 10/27/2011 | WO2011046622A3 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
| 10/27/2011 | WO2011045570A3 Elisa signal amplification system using magnetic bead movement detection |
| 10/27/2011 | WO2011044469A3 Diagnostic methods for oral cancer |
| 10/27/2011 | WO2011041703A3 Sample preparation devices and methods |
| 10/27/2011 | WO2010136163A8 Secernin-1 as a marker for cancer |
| 10/27/2011 | WO2010064196A4 Device for determining thermal conductivity and methods for the use thereof |
| 10/27/2011 | WO2010003044A3 Epithelial layer detector and related methods |
| 10/27/2011 | WO2002023190A8 Methods and products related to low molecular weight heparin |
| 10/27/2011 | US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof |
| 10/27/2011 | US20110265192 Nuclear receptor sensor system in transgenic animal |
| 10/27/2011 | US20110264380 Determination of the hydrodynamic radii and/or content of constituents of a mixture by analysis of the taylor dispersion of the mixture in a capillary tube |
| 10/27/2011 | US20110264378 Method, System, and Computer Program Product For Tracking of Blood Glucose Variability in Diabetes |
| 10/27/2011 | US20110264377 Method and system for analysing data sequences |
| 10/27/2011 | US20110264042 Conductive polymer materials and applications thereof including monitoring and providing effective therapy |
| 10/27/2011 | US20110263955 Internal Observation Device for Object having Light Scattering Properties, Internal Body Observation Device, Endoscope for Internal Observation and Internal Observation Method |
| 10/27/2011 | US20110263924 Functionalized magnetic nanoparticle analyte sensor |
| 10/27/2011 | US20110263830 Process for the modulation of the antagonistic activity of a monoclonal antibody |
| 10/27/2011 | US20110263821 Prognosis and risk assessment in stroke patients by determining the level of marker peptides |
| 10/27/2011 | US20110263679 C12orf48 as a target gene for cancer therapy and diagnosis |
| 10/27/2011 | US20110263677 Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 10/27/2011 | US20110263523 Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms |
| 10/27/2011 | US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity |
| 10/27/2011 | US20110263515 Capture agents and related compositions, methods and systems |
| 10/27/2011 | US20110263483 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 10/27/2011 | US20110263457 Multiplex Cellular Assays Using Detectable Cell Barcodes |
| 10/27/2011 | US20110263453 Nucleic acid quantification products and processes |
| 10/27/2011 | US20110263450 Alzheimer's disease biomarkers |
| 10/27/2011 | US20110263446 Kit useful for detecting, separating and/or characterizing a molecule of interest |
| 10/27/2011 | US20110263442 Method of using biomarkers |
| 10/27/2011 | US20110263441 Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders |
| 10/27/2011 | US20110263439 Markers associated with alzheimer's disease |
| 10/27/2011 | US20110263438 Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin |
| 10/27/2011 | US20110263437 Analysis of Y-Chromosome STR Markers |
| 10/27/2011 | US20110263435 Genetic markers for boar taint |
| 10/27/2011 | US20110263048 Insoluble carrier for use in anti-phospholipid antibody measurement reagent, anti-phospholipid antibody measurement reagent, and method for measuring anti-phospholipid antibody |
| 10/27/2011 | US20110263047 Peptide tag and uses thereof |
| 10/27/2011 | US20110263046 Methods of identification of novel ligands for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (NR1F3) activity |
| 10/27/2011 | US20110263045 Method of Detection of Nucleic Acids With a Specific Sequence Composition |
| 10/27/2011 | US20110263044 Device and method for the automatic detection of biological particles |